Jiangsu Hengrui Medicine
600276.SS
#489
Rank
C$59.28 B
Marketcap
$9.29
Share price
-1.55%
Change (1 day)
5.18%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of September 2024 : C$4.60 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has C$4.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$3.51 B-6.09%
2021-12-31C$3.74 B16.55%
2020-12-31C$3.21 B26.68%
2019-12-31C$2.53 B14.72%
2018-12-31C$2.21 B168.05%
2017-12-31C$0.82 B-13.26%
2016-12-31C$0.95 B-13.47%
2015-12-31C$1.09 B69.97%
2014-12-31C$0.64 B69.42%
2013-12-31C$0.38 B79.94%
2012-12-31C$0.21 B38%
2011-12-31C$0.15 B2.15%
2010-12-31C$0.15 B38.07%
2009-12-31C$0.10 B31.23%
2008-12-31C$83.02 M-28.05%
2007-12-31C$0.11 B34.18%
2006-12-31C$85.99 M38.12%
2005-12-31C$62.25 M17.88%
2004-12-31C$52.81 M67.38%
2003-12-31C$31.55 M-13.6%
2002-12-31C$36.51 M-29.98%
2001-12-31C$52.15 M-40.42%
2000-12-31C$87.53 M411.66%
1999-12-31C$17.1 M225.2%
1998-12-31C$5.26 M16.93%
1997-12-31C$4.49 M